24 Jun 2026
Honasa Consumer, the parent of Mamaearth, approved the acquisition of a 58% stake in Fluence Pharma at an enterprise value of about Rs 135 crore and set up a wholly owned subsidiary to enter the nutraceuticals business.
The move pushes the company beyond personal care into health-led consumer products, a higher-margin adjacency.

Anand Ganapathy K | SEBI Registered Research Analyst | INH000016630. Stock notes are market commentary for general information and education. They are not investment advice, not a recommendation to buy or sell, and do not account for any individual's financial situation. Investment in securities is subject to market risks. Please read all related documents carefully before investing. Past performance is not a guarantee of future results.